Predictors of treatment with dialysis modalities in observational studies for comparative effectiveness research. 2015

Sooraj Kuttykrishnan, and Kamyar Kalantar-Zadeh, and Onyebuchi A Arah, and Alfred K Cheung, and Steve Brunelli, and Patrick J Heagerty, and Ronit Katz, and Miklos Z Molnar, and Allen Nissenson, and Vanessa Ravel, and Elani Streja, and Jonathan Himmelfarb, and Rajnish Mehrotra
Kidney Research Institute, Division of Nephrology, University of Washington, Seattle, WA, USA.

BACKGROUND The Institute of Medicine has identified the comparative effectiveness of renal replacement therapies as a kidney-related topic among the top 100 national priorities. Given the importance of ensuring internal and external validity, the goal of this study was to identify potential sources of bias in observational studies that compare outcomes with different dialysis modalities. METHODS This observational cohort study used data from the electronic medical records of all patients that started maintenance dialysis in the calendar years 2007-2011 and underwent treatment for at least 60 days in any of the 2217 facilities operated by DaVita Inc. Each patient was assigned one of six dialysis modalities for each 91-day period from the date of first dialysis (thrice weekly in-center hemodialysis (HD), peritoneal dialysis (PD), less-frequent HD, home HD, frequent HD and nocturnal in-center HD). RESULTS Of the 162 644 patients, 18% underwent treatment with a modality other than HD for at least one 91-day period. Except for PD, patients started treatment with alternative modalities after variable lengths of treatment with HD; the time until a change in modality was shortest for less-frequent HD (median time = 6 months) and longest for frequent HD (median time = 15 months). Between 30 and 78% of patients transferred to another dialysis facility prior to change in modality. Finally, there were significant differences in baseline and time-varying clinical characteristics associated with dialysis modality. CONCLUSIONS This analysis identified numerous potential sources of bias in studies of the comparative effectiveness of dialysis modalities.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence
D057186 Comparative Effectiveness Research Conduct and synthesis of systematic research comparing interventions and strategies to prevent, diagnose, treat, and monitor health conditions. The purpose of this research is to inform patients, providers, and decision-makers, responding to their expressed needs, about which interventions are most effective for which patients under specific circumstances. (hhs.gov/recovery/programs/cer/draftdefinition.html accessed 6/12/2009) Effectiveness Research, Comparative,Research, Comparative Effectiveness

Related Publications

Sooraj Kuttykrishnan, and Kamyar Kalantar-Zadeh, and Onyebuchi A Arah, and Alfred K Cheung, and Steve Brunelli, and Patrick J Heagerty, and Ronit Katz, and Miklos Z Molnar, and Allen Nissenson, and Vanessa Ravel, and Elani Streja, and Jonathan Himmelfarb, and Rajnish Mehrotra
December 2018, Journal of periodontal & implant science,
Sooraj Kuttykrishnan, and Kamyar Kalantar-Zadeh, and Onyebuchi A Arah, and Alfred K Cheung, and Steve Brunelli, and Patrick J Heagerty, and Ronit Katz, and Miklos Z Molnar, and Allen Nissenson, and Vanessa Ravel, and Elani Streja, and Jonathan Himmelfarb, and Rajnish Mehrotra
July 2023, Annals of vascular surgery,
Sooraj Kuttykrishnan, and Kamyar Kalantar-Zadeh, and Onyebuchi A Arah, and Alfred K Cheung, and Steve Brunelli, and Patrick J Heagerty, and Ronit Katz, and Miklos Z Molnar, and Allen Nissenson, and Vanessa Ravel, and Elani Streja, and Jonathan Himmelfarb, and Rajnish Mehrotra
August 2013, Journal of evaluation in clinical practice,
Sooraj Kuttykrishnan, and Kamyar Kalantar-Zadeh, and Onyebuchi A Arah, and Alfred K Cheung, and Steve Brunelli, and Patrick J Heagerty, and Ronit Katz, and Miklos Z Molnar, and Allen Nissenson, and Vanessa Ravel, and Elani Streja, and Jonathan Himmelfarb, and Rajnish Mehrotra
June 2013, American journal of respiratory and critical care medicine,
Sooraj Kuttykrishnan, and Kamyar Kalantar-Zadeh, and Onyebuchi A Arah, and Alfred K Cheung, and Steve Brunelli, and Patrick J Heagerty, and Ronit Katz, and Miklos Z Molnar, and Allen Nissenson, and Vanessa Ravel, and Elani Streja, and Jonathan Himmelfarb, and Rajnish Mehrotra
January 2015, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting,
Sooraj Kuttykrishnan, and Kamyar Kalantar-Zadeh, and Onyebuchi A Arah, and Alfred K Cheung, and Steve Brunelli, and Patrick J Heagerty, and Ronit Katz, and Miklos Z Molnar, and Allen Nissenson, and Vanessa Ravel, and Elani Streja, and Jonathan Himmelfarb, and Rajnish Mehrotra
December 2010, The American journal of medicine,
Sooraj Kuttykrishnan, and Kamyar Kalantar-Zadeh, and Onyebuchi A Arah, and Alfred K Cheung, and Steve Brunelli, and Patrick J Heagerty, and Ronit Katz, and Miklos Z Molnar, and Allen Nissenson, and Vanessa Ravel, and Elani Streja, and Jonathan Himmelfarb, and Rajnish Mehrotra
March 2012, Circulation. Cardiovascular quality and outcomes,
Sooraj Kuttykrishnan, and Kamyar Kalantar-Zadeh, and Onyebuchi A Arah, and Alfred K Cheung, and Steve Brunelli, and Patrick J Heagerty, and Ronit Katz, and Miklos Z Molnar, and Allen Nissenson, and Vanessa Ravel, and Elani Streja, and Jonathan Himmelfarb, and Rajnish Mehrotra
May 2011, Epidemiology (Cambridge, Mass.),
Sooraj Kuttykrishnan, and Kamyar Kalantar-Zadeh, and Onyebuchi A Arah, and Alfred K Cheung, and Steve Brunelli, and Patrick J Heagerty, and Ronit Katz, and Miklos Z Molnar, and Allen Nissenson, and Vanessa Ravel, and Elani Streja, and Jonathan Himmelfarb, and Rajnish Mehrotra
May 2022, International orthopaedics,
Sooraj Kuttykrishnan, and Kamyar Kalantar-Zadeh, and Onyebuchi A Arah, and Alfred K Cheung, and Steve Brunelli, and Patrick J Heagerty, and Ronit Katz, and Miklos Z Molnar, and Allen Nissenson, and Vanessa Ravel, and Elani Streja, and Jonathan Himmelfarb, and Rajnish Mehrotra
September 2015, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery,
Copied contents to your clipboard!